Brad Niles

Brad Niles is the CEO of ARIZ Precision Medicine. Brad has previously worked as a Senior Scientist at AFINGEN, Inc., a Biologist Affiliate Scientist at the Joint BioEnergy Institute & Lawrence Berkeley National Lab, and an Assistant Project Scientist at UC Davis. Brad has also interned at Monsanto as part of their Designated Emphasis in Biotechnology Program. Brad's experience and expertise lies in the areas of engineering yeast for production of biofuel compounds, performing microarray analysis, and re-engineering metabolic signaling pathways. Brad is also skilled in lab management, including training and managing students.

Brad Niles has earned a Doctor of Philosophy in Nutritional Biology with a Designated Emphasis in Biotechnology from the University of California, Davis. Brad also holds a Bachelor of Science in Physiology from UC San Diego. In addition, they have received certification from the UC Entrepreneurship Academy at UC Davis in Special Training in Business Development.

A direct report to Brad Niles is and Glenn Kazo - Chief Business Officer.